HOSPITAL-BASED CLINICAL STUDY ON PREVALENCE OF TPO ANTIBODIES IN ASSOCIATION TO AUTOIMMUNE THYROID DISEASES IN TERTIARY CARE HOSPITAL
Objective: Autoimmune thyroid disease is one of the organs specific autoimmune disorders. The onset is much more common in women than in men. Worldwide, 2–4% of women and only 1% of men have affected and the rate increases with age. Thyroperoxidase (TPO) antibodies (Abs) level helps to diagnose autoimmune thyroid disease along with levels of thyroid stimulating hormone (TSH), Free Tri-iodotyrosine (Free T3), and Free Thyroxin(Free T4) and it helps in differentiation between subclinical and overt thyroidism. The core objective of clinical study was to evaluate prevalence of anti-TPO Abs in association to autoimmune thyroid disease in a tertiary care hospital – Punjab.
Methods: A cross-sectional study of random patient (n=200 patients) at a tertiary care hospital, Mohall – Punjab was carried out. All the patients fall in the age group 12–89 years. The parameters, which were used for the diagnosis of autoimmune thyroid disease, were anti-TPO level, Free T3 level, and Free T4 level. The patients were divided in different group on the basis of their age, gender, and their clinical conditions. The level of TPO Abs, TSH, Free T3, and Free T4 was noted for each patient. Electrochemiluminescence immunoassay method was used for determination of TPO Abs and other thyroid parameters. After a period of 16 weeks, subjects from different groups had great difference in their anti-TPO values in the autoimmune thyroid disease.
Results: TPO Abs positive is one of the most common associated with hypothyroidism which was 36.5%, among them 20.5% suffered from subclinical hypothyroidism, whereas other remaining suffered from clinical hypothyroidism, clinical hyperthyroidism, and other autoimmune disease.
Conclusion: TPO Abs level helps to diagnose autoimmune thyroid disease, along with this the level of TSH, Free T3, and Free T4 helps in differentiation between subclinical and overt thyroidism.
2. Gilman AG, Rall TW, Nies AS. Thyroid and antithyroid drugs. In: Haynes RC, editor. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 8th ed. Oxford, United Kingdom: Pergamon Press; 1990. p. 1361.
3. Gerard J, Tortora BD. Principles of Anatomy and Physiology. 12th ed. United States: John Wiley & Sons; 2009.
4. Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance. Netherlands J Med 1995;46:197-204.
5. Swain M, Swain T, Mohanty BK. Autoimmune thyroid disorders-an update. Indian J Clin Biochem 2005;20:9-17.
6. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-34.
7. Holt PG. Immune and inflammatory function in cigarette smokers. Thorax 1987;42:241-9.
8. Nelson JL, Steinberg AD. Sex steroids, autoimmunity and autoimmune disease. In: Berczi I, Kovacs K, editors. Hormones and Immunity. Lancaster, UK: MTP Press; 1987. p. 93-119.
9. Gey A, Diallo A, Seneschal J, Leaute-Labreze C, Boralevi F, Jouary T, et al. Autoimmune thyroid disease in vitiligo: Multivariate analysis indicates intricate pathomechanisms. Br J Dermatol 2013;168:756-61.
10. Wu AH. Tietz Clinical Guide to Laboratory Tests, Section II. 4th ed. Philadelphia, PA: Saunders Elsevier; 2006. p. 1076-7.
11. Brent GA. Thyroid Function Testing. 1st ed., Ch. 5. Berlin: Springer; 2010. p. 86-8.
12. Wheeler MH, Lazarus JH. Diseases of the Thyroid. London, Glasgow, Weinheim, New York, Tokyo, Melbourne, Madras: Chapman and Hall; 1994. p. 107-15.
13. Pfannenstiel P, Saller B. Schilddrüsenkrankheiten Diagnose und Therapie. Vol. 2. Berlin: Berliner Medizinische Verlagsanstalt; 1991. p. 43-62, 72-89.
14. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American thyroid association guidelines for the use of laboratory tests in thyroid disorders. JAMA 1990;263:1529-32.
15. Keffer JH. Preanalytical considerations in testing thyroid function. Clin Chem 1996;42:125-35.
16. Ladenson PW. Optimal laboratory testing for diagnosis and monitoring of thyroid nodules, goiter and thyroid cancer. Clin Chem 1996;42:183-7.
17. Nicoloff JT, Spencer CA. The use and misuse of the sensitive thyrotropin assays. J Clin Endocr Metab1990;71:553-8.
18. Menon VU, Sundaram KR, Unnikrishnan AG, Jayakumar RV, Nair V, Kumar H. High prevalence of undetected thyroid disorders in an iodine sufficient adult South Indian population. J Indian Med Assoc 2009;107:72-7.
19. Silva LM, Chavez J, Canalli MH, Zanetti CR. Determination of IgG subclasses and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism-a comparison with patients with overt hypothyroidism. Horm Res 2003;59:118-24.
20. Lock RJ, Marden NA, Kemp HJ, Thomas PH, Goldie DJ, Gompels MM. Subclinical hypothyroidism: A comparison of strategies to achieve adherence to treatment guidelines. Ann Clin Biochem 2004;41:197.
21. Unnikrishnan AG, Kalra S, Sahay RK, Bantwal G, John M, Tewari N. Prevalence of hypothyroidism in adults: An epidemiological study in eight cities of India. Indian J Endocrinol Metab 2013;17:647-52.
22. Marwaha RK, Tandon N, Ganie MA, Kanwar R, Garg MK, Singh S. Status of thyroid function in Indian adults: Two decades after universal salt iodization. J Assoc Physicians India 2012;60:32-6.
23. Jeena EJ, Malathi M, Sudeep K. A hospital-based study of anti-TPO titer in patients with thyroid disease. J Med Sci Res 2013;4:74-7.
24. Atluri S, Boppana R, Goel A, Yalamanchi A, Biswas A, Shivaprasad C. Prevalence of elevated anti-thyroid peroxidase antibodies in subclinical hypothyroidism. IJCMR 2018;5:C1-4.
25. Sindhu PS, Pushpalatha M, Anil P. Antithyroid peroxidase antibody prevalence in reproductive age group females-a study from Central Kerala, India. India J Evid Based Med Health 2017;4:1336-40.
26. Amouzegar A, Gharibzadeh S, Kazemian E, Mehran L, Tohidi M, Azizi F. The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: Tehran thyroid study. PLoS One 2017;12:1.
27. Pedersen IB, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Laurberg P. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf) 2003;58:36-42.
28. Gupta HR, Sheth SP, Vaishnav BS. Association of subclinical hypothyroidism with metabolic syndrome: A cross-sectional study from Western India. Asian J Pharm Clin Res 2016;9:265-9.
29. Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocr J 2007;54:71-6.
30. Klein I. Endocrine disorders and cardiovascular disease. In: Mann DL, Zipes DP, Libby P, Bonow RO, editors. Braun Wald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, PA: Saunders, Elsevier; 2015. p. 1793-808.
31. Shantha GP, KumarAA, Jeyachandran V, Rajamanickam D, Rajkumar K, Salim S, et al. Association between primary hypothyroidism and metabolic syndrome and the role of C reactive protein: A cross-sectional study from South India. Thyroid Res 2009;2:2.
32. Waring AC, Rodondi N, Harrison S, Kanaya AM, Simonsick EM, Miljkovic I, et al. Thyroid function and prevalent and incident metabolic syndrome in older adults: The health, ageing and body composition study. Clin Endocrinol (Oxf) 2012;76:911-8.
33. Fatourechi V. Subclinical hypothyroidism: An update for primary care physicians. Mayo Clin Proc 2009;84:65-71.
34. Cooper DS. Subclinical hypothyroidism. JAMA 1987;258:246-7.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.